Browse Items (2 total)
- Tags: Hepatocytes/drug effects/pathology
Resveratrol and liver disease: from bench to bedside and community.
Tags: 2010, Acetaminophen/metabolism, Anti-Inflammatory Agents, Antioxidants/therapeutic use, Bishayee Anupam, Carbon Tetrachloride/metabolism, Cytokines/metabolism, Darvesh Altaf S, Department of Pharmaceutical Sciences, Ethanol/metabolism, Free Radicals/metabolism, Glutathione/metabolism, Hepatocytes/drug effects/pathology, Humans, Liver Diseases/*drug therapy/epidemiology, Liver international : official journal of the International Association for the Study of the Liver, McGory Robb, NEOMED College of Pharmacy, NF-kappa B/antagonists & inhibitors, Non-Steroidal/therapeutic use, Politis Themos, Resveratrol, Stilbenes/pharmacokinetics/*pharmacology/therapeutic use/toxicity
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
Tags: *Chemoprevention, 2011, Analysis of Variance, Animal, Animal Studies, Animal/drug effects, Animals, Antioxidants, Behavior, Bishayee Anupam, Blotting, Booth Tristan D, Carcinoma, Cardiotoxicity, Cardiotoxins/*toxicity, Chemoprevention, Data Analysis Software, Department of Integrative Medical Sciences, Descriptive Statistics, Disease Models, Doppler, Dose-Response Relationship, Drug, Echocardiography, Feeding Behavior/drug effects, Female, Fisher's Exact Test, Funding Source, Heart – Drug Effects, Heart/drug effects/physiopathology, Hepatocellular – Prevention and Control, Hepatocellular/*drug therapy/pathology/physiopathology, Hepatocytes/drug effects/pathology, Hodnichak Cheryl M, Humans, Investigational new drugs, Liver Neoplasms/*drug therapy/pathology/physiopathology, Liver/drug effects/pathology/physiopathology, Luther Daniel J, Meszaros J Gary, NEOMED College of Medicine, Ohanyan Vahagn, Polyphenols – Therapeutic Use, Rats, Resveratrol, Shamhart Patricia E, Sisakian Hamayak, Sprague-Dawley, Stilbenes/*therapeutic use, Systole/drug effects, Western